Karolinska Institutet Science Park
Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization.
Founder: Ulf Schr?der
CEO: Hans Arwidsson
CSO: Anna-Karin Maltais
Please click here for clinical trial information.